Development
Chemistry Nobel goes to reactions like those that gave life a hand
October 8, 2026 Development Source: Ars Technica
Share this article
All of these were hypotheticals, however, until the researchers being honored got to work. Henri Kagan of the University of Paris-Sud also approached his work very theoretically, describing the factors that would be needed to drive reactions that favored a single chirality. But in several cases, he was able to go out and find actual chemical reactions that demonstrated his ideas mattered in the real world.
Kagan worked with a catalyst that was itself chiral. He found that, in a mix of L and D versions of his catalyst, one of the forms was much more active than the other. While the forms might be present at the same level, most of the actual catalysis was performed by just one of them. And, if it was used to catalyze a reaction that produced a chiral product, this difference could lead to much higher levels of a single chirality.
By the mid-1960s, Kagan had found three different reactions that could produce an excess of a single chiral form. Other researchers who followed up on his ideas showed that chiral catalysts could also be selectively activated or inhibited by the addition of non-chiral chemicals, allowing a finer degree of control that found its way into the production of pharmaceuticals.
About a decade later, Tokyo University’s Kenzo Soai was working on reactions where one of the products of the reaction acted as a catalyst to boost the same reaction. Eventually, he found one that selected for chirality; one form of the reaction product would catalyze the formation of more molecules of the same chirality. He started the reaction with a slight excess of one form of catalyst and found that, after a single round of reactions, the excess in the catalyst had risen to 55 percent. Using that as a catalyst for a new round of reactions would enhance the excess further; after several rounds, 90 percent of the products were a single chirality.
Eventually, Soai found conditions where one product would not only catalyze the formation of more of the same form, but inhibit the formation of the opposite chirality. This allowed him to start with a tiny excess of a single chiral form (0.00005 percent more) and, after a few rounds of reactions, bring the excess to over 99 percent.
Others later found conditions where a similar reaction that reached an equilibrium of forward and back reactions would gradually lead to a single chiral form dominating.
There are three different aspects of this work that are worth celebrating. One is that it’s simply great science; people reasoned through the ways that an excess of one chiral form could emerge, and then others found ways to demonstrate that the behavior took place in the real world. A second is that it has immense practical applications. Many of our drugs work because they interact with proteins, where chirality often matters. And there are many examples of drugs where the wrong chiral form can be inactive or positively harmful. So finding new ways to catalyze the production of specific chiral forms has a lot of utility.
But the final thing comes back to the origin of life. None of these reactions were demonstrated with anything closely related to a biomolecule, so it’s not obvious that this particular work is directly relevant to the origin of life. But it does show that small excesses of some chiral forms—smaller than the 90 percent seen in this work, but still significant—may be common in the natural world.
The current thinking is that those small differences weren’t decisive, but did help push the emergence of life along a pathway that ultimately led to the exclusive chemistry we see now.